Virtual screening and in vitro assay of potential inhibitors against dengue-2 NS2B-NS3 protease.
| dc.contributor.author | Ganesh, Vanee | |
| dc.date.accessioned | 2018-08-28T07:50:48Z | |
| dc.date.available | 2018-08-28T07:50:48Z | |
| dc.date.issued | 2016-09 | |
| dc.description.abstract | Walaupun penyakit denggi merupakan beban global semasa yang tinggi, namun sehingga kini tidak ada penawar yang pasti untuk denggi. Walaupun terdapat usaha-usaha pembangunan vaksin yang dijalankan , cabaran imunisasi yang sukar diatasi adalah perlindungan lengkap terhadap kesemua empat serotype di mana perlindungan imunisasi yang tidak lengkap boleh menyebabkan pesakit yang mempunyai risiko untuk menghidapi Demam Hemoragik Denggi (DHF) dan Sindrom Kejutan Denggi (DSS). Despite the current global burden, there has been no definite cure for dengue. Although efforts on vaccine development are ongoing, the strategy faces challenges of constant immunization, where by incomplete protection against all four serotypes may lead to patients at risk of progressing to dengue haemmorhagic fever (DHF) and dengue shock syndrome (DSS). | en_US |
| dc.identifier.uri | http://hdl.handle.net/123456789/6438 | |
| dc.language.iso | en | en_US |
| dc.publisher | Universiti Sains Malaysia | en_US |
| dc.subject | Virtual | en_US |
| dc.subject | Dengue | en_US |
| dc.title | Virtual screening and in vitro assay of potential inhibitors against dengue-2 NS2B-NS3 protease. | en_US |
| dc.type | Thesis | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: